Pancreaze DR 37,000 unit cap 50S
Ended Awarded
- Contract number
- SPE2DR26F71TA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,308
Award facts
- Contract value 100% obligated
- $26,307.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,307.51 to AmerisourceBergen Drug Corp for 37,000 units of Pancreaze DR in 50-count capsule bottles. This competitively awarded, firm fixed-price contract was issued on October 28, 2025, with an ultimate completion date of October 29, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies essential medications and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Pancreaze DR, a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency, represents the type of specialized pharmaceutical product routinely delivered through the company's federal contract portfolio. The absence of a set-aside designation indicates this award was made through open competition, consistent with AmerisourceBergen's typical federal procurement pattern and its established capability to meet rigorous federal medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26F71TA?
SPE2DR26F71TA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26F71TA worth?
The government has obligated $26,308 on SPE2DR26F71TA.
Is contract SPE2DR26F71TA an order under another contract?
Yes. SPE2DR26F71TA is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F71TA competed?
The extent of competition for SPE2DR26F71TA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award